Side-by-side comparison of AI visibility scores, market position, and capabilities
ByteDance's AI chatbot with 100M+ DAU and 226M MAU leading China's AI market; Doubao 2.0 launched Feb 2026 claiming GPT-5.2-level reasoning at 10x lower cost
Doubao is ByteDance's flagship consumer AI chatbot and assistant platform, launched to compete directly with ChatGPT and other frontier AI products in China's rapidly growing AI market. Built on ByteDance's proprietary large language model stack, Doubao was designed to deliver a general-purpose conversational AI experience optimized for Chinese language, culture, and use cases — while also competing on raw model capability against international benchmarks. The product benefits from ByteDance's massive distribution infrastructure across TikTok, Toutiao, and its broader content and entertainment ecosystem.\n\nDoubao serves as both a standalone AI app and the intelligence layer embedded across ByteDance's product portfolio, powering features in video creation, content recommendation, customer service, and education applications. The February 2026 launch of Doubao 2.0 introduced a model that ByteDance claimed achieved GPT-5.2-level reasoning performance at approximately 10 times lower inference cost — a significant efficiency claim that attracted wide attention in the AI research community. The platform supports text, image, code, and multimodal interactions and offers API access for enterprise developers.\n\nDoubao has reached 100 million or more daily active users and 226 million monthly active users, establishing it as the market leader in China's AI chatbot category. This scale makes Doubao one of the most-used AI assistants globally by user count, rivaling ChatGPT's reported usage figures. ByteDance's ownership provides nearly unlimited distribution, engineering talent, and infrastructure scale — advantages that make Doubao a formidable competitor not just in China but increasingly in international markets where ByteDance's consumer apps already have significant reach.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.